NCT04092439
The Effects of Watermelon Juice Supplementation on Postprandial Vascular Endothelial Function
The Effects of Watermelon Juice Supplementation on Postprandial Vascular Endothelial Function and Blood Flow During Hyperglycemia: A Pilot Study
Pennington Biomedical Research Center·ClinicalTrials.gov·dietary supplementCompleted
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Endothelial Dysfunction
- Drug/Device/Intervention
- Watermelon Juice
- Study type
- Interventional
- Intervention type
- dietary supplement
Sponsor & location
- Primary sponsor
- Pennington Biomedical Research Center
- Location
- Baton Rouge, United States of America
Timeline & enrollment
- Phase
- N/A
- Start date
- Sep 12, 2019
- End date
- Mar 20, 2020
- Enrollment
- 18 participants
Primary outcome
Endothelial Function
Summary
The purpose of this study is to test if watermelon juice supplementation improves vascular
 dysfunction experience during hyperglycemia.
ICD-10 classifications
Other peripheral vascular diseasesAtherosclerosis of arteries of extremitiesOther specified peripheral vascular diseasesRenovascular hypertensionOther disorders of arteries and arterioles
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT04092439
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT04092439 through Pure Global AI's free database. This phase not specified trial is sponsored by Pennington Biomedical Research Center and is currently Completed. The study focuses on Endothelial Dysfunction. Target enrollment is 18 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.